Scarica l'app Stockscreener
1.975
3.99%
0.095
Precedente Chiudi:
$1.88
Aprire:
$1.9
Volume 24 ore:
1.80M
Relative Volume:
0.69
Capitalizzazione di mercato:
$652.16M
Reddito:
-
Utile/perdita netta:
$-75.80M
Rapporto P/E:
-5.6429
EPS:
-0.35
Flusso di cassa netto:
$-68.07M
1 W Prestazione:
+11.71%
1M Prestazione:
-6.46%
6M Prestazione:
-19.55%
1 anno Prestazione:
-27.32%
Intervallo 1D:
$1.885
$1.985
Intervallo di 1 settimana:
$1.7211
$2.08
Portata 52W:
$1.54
$3.97
Nuvation Bio Inc Stock (NUVB) Company Profile
Nome
Nuvation Bio Inc
Settore
Industria
Telefono
(415) 754-3517
Indirizzo
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
Confronta NUVB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
1.975 | 652.16M | 0 | -75.80M | -68.07M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
490.15 | 125.96B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 60.97B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
599.08 | 36.45B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
231.77 | 30.16B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.36 | 24.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-03-27 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-03-26 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-01-06 | Downgrade | Jefferies | Buy → Hold |
| 2022-08-02 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2022-08-02 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-05-04 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-15 | Ripresa | BTIG Research | Buy |
| 2021-04-06 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-03-08 | Iniziato | BMO Capital Markets | Outperform |
| 2021-03-08 | Iniziato | BTIG Research | Buy |
| 2021-03-08 | Iniziato | Cowen | Outperform |
| 2021-03-08 | Iniziato | Jefferies | Buy |
| 2021-03-08 | Iniziato | Wedbush | Outperform |
Mostra tutto
Nuvation Bio Inc Borsa (NUVB) Ultime notizie
Is Nuvation Bio Inc. (NYSE:NUVB) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Insider Monkey
Is Nuvation Bio Inc. (NUVB) the Top Healthcare Stock to Buy According to Billionaire David Einhorn? - Yahoo Finance
Wellington Management Group LLP Raises Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio Inc. (NYSE:NUVB) Shares Acquired by Vanguard Group Inc. - Defense World
Corebridge Financial Inc. Cuts Stake in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
American Century Companies Inc. Raises Stock Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
KLP Kapitalforvaltning AS Acquires Shares of 43,500 Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio Inc. (NUVB): Among Stocks Under $10 that Will Triple - Insider Monkey
Nuvation Bio CEO David Hung purchases $820,220 in company stock - Investing.com Australia
Nuvation Bio CEO David Hung purchases $820,220 in company stock By Investing.com - Investing.com Canada
10 Stocks Under $10 that Will Triple - Insider Monkey
Institutional owners may take dramatic actions as Nuvation Bio Inc.'s (NYSE:NUVB) recent 8.8% drop adds to one-year losses - simplywall.st
Teacher Retirement System of Texas Increases Stock Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio to Present at the Jones Healthcare and Technology Innovation Conference - BioSpace
Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE) and Nuvation Bio (NUVB) - The Globe and Mail
Nuvation Bio Inc (NYSE: NUVB) – An Analysis Is What You Need - stocksregister.com
Nuvation Bio (NYSE:NUVB) Reaches New 52-Week LowHere's Why - MarketBeat
Quantbot Technologies LP Decreases Stock Holdings in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio stock hits 52-week low at $1.7 amid market challenges - Investing.com
Swiss National Bank Buys 136,600 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Wedbush Reaffirms “Outperform” Rating for Nuvation Bio (NYSE:NUVB) - Defense World
Nuvation Bio Inc (NYSE: NUVB) Has Great Upside Potential - Stocks Register
Nuvation Bio (NYSE:NUVB) Receives Outperform Rating from Wedbush - The AM Reporter
Nuvation Bio Inc. (NYSE:NUVB) Stock Position Boosted by Charles Schwab Investment Management Inc. - Defense World
Nuvation Bio to Present New Nonclinical Data for Taletrectinib at the American Association for Cancer Research Annual Meeting 2025 - BioSpace
Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Crizotinib During Mini Oral Presentation at the European Lung Cancer Congress 2025 - BioSpace
Nuvation Bio Enters Supply Agreement With Asymchem For Taletrectinib - Marketscreener.com
Insider Stock Buying Reaches US$720.1k On Nuvation Bio - Yahoo Finance
Breakthrough Lung Cancer Treatment Comparison: Taletrectinib Shows Head-to-Head Data vs Standard Therapy - Stock Titan
Bank of New York Mellon Corp Buys 14,203 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio Sees Unusually High Options Volume (NYSE:NUVB) - Defense World
Nuvation Bio Inc (NYSE: NUVB) Is The Number One Stock Currently Moving. - Stocks Register
Is Nuvation Bio Inc. (NYSE:NUVB) the Most Oversold Penny Stocks to Buy According to Analysts? - Insider Monkey
Arizona State Retirement System Grows Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
10 Most Oversold Penny Stocks to Buy According to Analysts - Insider Monkey
Analysts Set Nuvation Bio Inc. (NYSE:NUVB) Target Price at $8.33 - Defense World
Nuvation Bio Inc (NUVB): Be Patient, You Will Learn - Stocks Register
Jones Trading Begins Coverage on Nuvation Bio (NYSE:NUVB) - Defense World
Q1 EPS Estimates for Nuvation Bio Decreased by HC Wainwright - Defense World
Jones Trading Initiates Coverage of Nuvation Bio (NUVB) with Buy Recommendation - Nasdaq
Nuvation Bio Positioned for Growth with Key Therapeutics and Strategic Leadership - TipRanks
Jones Trading sets $10 target for Nuvation Bio stock with Buy rating - Investing.com Australia
Jones Trading sets $10 target for Nuvation Bio stock with Buy rating By Investing.com - Investing.com South Africa
Nuvation Bio initiated with a Buy at JonesResearch - TipRanks
Nuvation Bio (NYSE:NUVB) Shares Gap Down Following Analyst Downgrade - Defense World
Nuvation Bio (NYSE:NUVB) Price Target Cut to $10.00 by Analysts at HC Wainwright - Defense World
Nuvation Bio Inc Azioni (NUVB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):